The Medicines and Healthcare products Regulatory Agency (MHRA) has approved catumaxomab (Korjuny) to treat malignant ascites in adults when standard treatment of their cancer is no longer feasible. Malignant ascites is a build-up of fluid containing cancer cells in the abdomen. Patients often need procedures to drain this fluid. Catumaxomab provides a treatment option that […]